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Pathogens are detected by a variety of innate immune sensors in host cells leading to rapid
induction of cell autonomous responses. Proinflammatory cytokine secretion and a spe-
cialized form of inflammatory cell death called pyroptosis are induced during infection
through activation of caspase-1. Pathogen-induced caspase-1 activation is regulated in
large part by a vast array of cystosolic sensor proteins, including NLRs and AIM2, and an
adaptor protein called ASC. Together, these proteins cooperate in forming caspase-1 acti-
vation platforms and, more importantly, direct caspase-1 toward cytokine secretion or cell
death.
IntroductIon
Caspase-1 is a key mediator of inflam-
mation  in  response  to  pathogen-derived
molecules and endogenous danger signals.
This  cysteine  protease  cleaves  a  large
repertoire of substrates leading to diverse
downstream  activities,  including  proin-
flammatory cytokine activation and secre-
tion [1], and induction of cell death [2]. Ac-
tivation of caspase-1 is regulated by up-
stream  sensor  proteins  and  adaptors,
including the nucleotide-binding domain,
leucine-rich  repeat  containing  proteins
(NLRs†), absent in melanoma 2 (AIM2),
and apoptosis-associated speck-like protein
containing a caspase recruitment domain
(ASC). These proteins are responsible for
To whom all correspondence should be addressed: Christopher L. Case, Section of Mi-
crobial Pathogenesis, Yale School of Medicine, Boyer Center for Molecular Medicine, 295
Congress Ave., New Haven, CT 06536. Tele: 203-737-2409; Fax: 203-703-2630; E-mail:
christopher.case@yale.edu.
†Abbreviations: NLR, nucleotide-binding domain, leucine-rich repeat containing protein;
LRR, leucine-rich repeat; CARD, caspase recruitment domain; NBD, nucleotide binding
domain; PYR, pyrin domain; BIR, baculovirus inhibitory domain; IAP, inhibitor of apoptosis
protein; TLR, Toll-like receptor; ROS, reactive oxygen species; T3SS, type III secretion
system; MDP, muramyl dipeptide; LF, lethal factor; MEK, mitogen-activated protein kinase
kinase.
Keywords: caspase-1, innate immune response, host/pathogen interactions, inflammatory
response to pathogens, inflammasomecoordinating  caspase-1  activation  com-
plexes in response to endogenous and for-
eign  molecules  associated  with  cellular
danger.
Understanding the regulation of cas-
pase-1activation is of particular importance,
as improper activation of caspase-1 in re-
sponse to endogenous molecules is associ-
ated  with  a  number  of  inflammatory
diseases. The hereditary disorders familial
Mediterranean fever (FMF), familial cold
autoinflammatory  syndrome  (FCAS),
Muckle-Wells  syndrome  (MWS),  and
chronic infantile cutaneous neurological ar-
ticular syndrome (CINCA) are each associ-
ated  with  excessive  activation  of
caspase-1-mediated  proinflammatory  cy-
tokine production. Similarly, diseases such
as Type 2 diabetes, gout, atherosclerosis, and
Alzheimer’s disease are associated with in-
creased caspase-1 activation and inflamma-
tion. Recent reviews have discussed in detail
the relationship between caspase-1 activa-
tion and inflammatory disorders [3,4].  
Major advances toward understanding
caspase-1  activation  and  regulation  have
come from examining the role of caspase-1
during the innate immune response to mi-
crobial pathogens. One major class of for-
eign agonists leading to caspase-1 activation
is composed of pathogen-derived molecules.
Pathogens including bacteria, viruses, and
protozoans have proven to be useful tools in
dissecting the regulation of caspase-1 and
the upstream proteins involved in activation.
This review will discuss the current under-
standing of caspase-1 activation and high-
light  studies  with  pathogens  that  have
uncovered new details in the regulation of
caspase-1-associated activities. 
nLrS, AIM2 And ASc: reguLAtorS
of cASpASe-1
Caspase-1 activation is regulated in part
by cytosolic sensor proteins comprised of
the NLRs and AIM2. NLRs are character-
ized primarily by their shared domain archi-
tecture.  The  C-terminal  region  typically
contains  a  leucine-rich  repeat  domain
(LRR),  and  the  region  immediately  up-
stream contains a nucleotide-binding do-
main (NBD). The N-terminal domains of
NLRs further subdivide these proteins into
distinct subfamily members. Members of the
NLRP subfamily contain a N-terminal pyrin
domain (PYR), while the NLRC proteins
contain  a  caspase  recruitment  domain
(CARD) at this position. The NAIP subfam-
ily members contain baculovirus inhibitory
domains (BIR) at their N-termini. Separate
from the NLRs, AIM2 is a member of the
PYHIN family of proteins and lacks both an
NBD and LRR region. Instead, this protein
contains a C-terminal HIN200 domain and
an N-terminal PYR domain.  
The N-terminal domains of NLRs and
AIM2 determine their ability to directly or
indirectly interact with caspase-1. Proteins
with CARD domains, such as NLRC4 and
NLRP1, are able to directly interact with
caspase-1 [5,6]. In contrast, AIM2 and the
NLRP  proteins,  with  the  exception  of
NLRP1, require an adaptor protein in order
to  interact  with  caspase-1.  This  adaptor,
known as ASC, is comprised of a PYD and
a CARD domain. This bipartite architecture
enables ASC to bridge PYD-containing pro-
teins with the CARD of caspase-1. Although
lacking PYD or CARD domains, NAIP pro-
teins were initially thought to interact with
caspase-1 through their BIR domains, which
share homology with BIR domains of in-
hibitor of apoptosis proteins (IAPs) that bind
to apoptotic caspases [7]. However, recent
studies indicate that NAIP proteins signal to
caspase-1 indirectly through binding inter-
actions with NLRC4 [8,9]. Through these
various routes of association, NLRs, AIM2,
and ASC interact with caspase-1, resulting
in formation of a caspase-1 activation com-
plex called an inflammasome [10]. The role
of inflammasome formation in caspase-1 ac-
tivities will be discussed in more detail in a
subsequent section.    
Genetic and biochemical evidence have
provided useful insight into the mechanistic
details behind NLR activation. The LRR do-
mains of NLRs are thought to act in a man-
ner  similar  to  LRRs  found  in  Toll-like
receptors (TLRs) and likely are important
for protein-protein or receptor-ligand inter-
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priate  agonist.  Furthermore,  LRRs  are
thought to be autoinhibitory to NLR func-
tion [5,8]. Until sensing of an appropriate
signal by the LRRs, it is believed that the
LRRs maintain the NLR in a conformational
state that prevents downstream activation
events. The central NBD found in NLRs has
been shown to bind nucleotides and promote
oligomerization of the NLR with itself and
other components in signaling complexes
[6,8]. Upon relief of autoinhibition by the
LRRs, it is thought that oligomerization is
initiated through the NBD while simultane-
ously exposing the N-terminal PYD, BIR, or
CARD domain in order to recruit down-
stream molecules such as ASC, caspase-1,
or another NLR. Ongoing studies continue
to examine the interplay between NLRs,
ASC, and caspase-1.   
One of the most heavily studied proteins
involved in caspase-1 activation is NLRP3.
The detailed mechanism for activation of this
NLR  is  a  major  area  of  research,  and
progress  has  been  made  in  recent  years.
NLRP3 activation requires two distinct sig-
nals prior to activation. The first signal, typ-
ically a TLR agonist, is known as a priming
event and involves transcriptional upregula-
tion of NLRP3 [11]. The second signal in-
volves stimulation with a NLRP3 agonist. A
diverse group of pathogen-derived and en-
dogenous molecules signal through NLRP3
to induce caspase-1 activation, suggesting
that NLRP3 is responding to an intermediate
signal rather than directly sensing any one of
these  microbial  or  host-derived  agonists.
Studies thus far have led to multiple models,
each  involving  the  sensing  of  a  general
change in the cellular environment following
stimulation with a given agonist. One pro-
posed model for activation involves reactive
oxygen species (ROS) production. ROS pro-
duction is a common event following expo-
sure  to  several  NLRP3  agonists  and  is
required for caspase-1 activation in multiple
instances [12-15]. However, recent data sug-
gest that the role of ROS may be further up-
stream  in  the  signaling  pathway  than
previously  thought  and  may  play  a  role
solely for priming, or transcriptional upreg-
ulation  of  NLRP3  [16].  Furthermore,
macrophages derived from mice deficient in
NOX2, a major producer of ROS in these
cells, are still competent for activation of cas-
pase-1 in response to a subset of NLRP3 ag-
onists, suggesting that ROS production is not
the sole player in this pathway [17]. A sec-
ond model argues that lysosomal leakage as
a result of membrane perturbation results in
caspase-1 activation. This model proposes
that proteases, which are normally active
only  in  lysosomal  compartments,  are  re-
leased into the cytosol following perturba-
tion of the phagosomal membrane during
endocytosis. The strongest evidence for this
model are data indicating that the lysosomal
protease cathepsin B plays an important role
in NLRP3-dependent caspase-1 activation in
response  to  several  agonists  [15,17-19].
However, much like the ROS model, the re-
quirement for cathepsin B does not appear to
be absolute as macrophages deficient for this
protease are still competent for induction of
caspase-1 activation in response to a subset
of agonists, suggesting that other proteases
or  activities  are  sufficient  for  induction
[18,19]. Finally, the most common feature of
NLRP3-induced inflammasome activation is
the requirement for potassium efflux. Potas-
sium efflux occurs in response to a number
of NLRP3 agonists, and many NLRP3-me-
diated pathways for caspase-1 activation are
efficiently inhibited by high levels of extra-
cellular potassium [12,15,20-23]. Although
the connection between potassium efflux and
NLRP3-mediated activation of caspase-1 re-
mains unclear, a role for the adaptor ASC has
been proposed. Biochemical data suggest
that under conditions of low potassium, ASC
oligomerizes more efficiently and provides a
better scaffold for the recruitment and acti-
vation of caspase-1 [24]. Therefore, in the
presence of an NLRP3 agonist, a resulting
loss of potassium may render the cytosol
more favorable for oligomerization of ASC
and promote more robust caspase-1 activa-
tion. However, it remains unclear if NLRP3
and sensing of potassium efflux are directly
linked since oligomerization of purified re-
combinant ASC and subsequent caspase-1
cleavage was found to occur in the absence
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duced in vitro[24]. In addition, potassium ef-
flux has been shown to be important for
NLRP3-independent  but  ASC-dependent
pathways leading to caspase-1 activation, ar-
guing that potassium efflux may be a more
general  requirement  for  ASC-dependent
pathways [25-27]. Regardless, it cannot be
ruled out that each of these hypotheses may
contribute at least partially to the overall
mechanism of activation for NLRP3. It is
possible that these three events ― ROS pro-
duction, lysosomal leakage, and potassium
efflux ― each result in a distinct signal that
is capable of signaling to NLRP3 either di-
rectly or through an intermediate molecule.
In support of this latter possibility, it has been
shown that ROS production promotes asso-
ciation  of  thioredoxin  interacting  protein
(TXNIP) with NLRP3 and that TXNIP is re-
quired for activation of caspase-1 in response
to NLRP3 agonists [28]. Future work identi-
fying  upstream  components  involved  in
sensing of NLRP3 agonists should further
clarify the mechanistic details behind activa-
tion of this sensor molecule.
cASpASe-1 ActIvAtIon by
pAthogenS
Bacterial, viral, and eukaryotic pathogens
have all been shown to induce caspase-1 acti-
vation. The mechanisms for activation by
these various pathogens share a number of
features, suggesting that caspase-1 is activated
in response to common activities or products
of pathogenic organisms. One key determi-
nant for the activation of caspase-1 is the es-
cape of microbial products into the host cell
cytosol and subsequent detection by NLRs
and AIM2. Microbial products gain access to
host cell cytosols through a number of mech-
anisms, including pore-forming activities of
toxins, specialized protein secretion systems
that inject microbial products into host cells,
or phagosomal leakage resulting from endo-
cytosis of microbial products.
NLRC4
A  major  implication  for  bacterial-in-
duced caspase-1 activation came with the
elucidation of NLRC4 as a key mediator in
the response to bacterial flagellin. NLRC4
has been shown to be involved in the re-
sponse  to  flagellin  during  infection  of
macrophages by Legionella pneumophila,
Salmonella enterica serovar Typhimurium,
and Listeria monocytogenes [29-35]. In ad-
dition, there exist flagellin-independent path-
ways leading to caspase-1 activation that
require NLRC4. The type III secretion sys-
tem (T3SS) rod protein is sensed in a manner
dependent on NLRC4. Pseudomonas aerug-
inosa, Shigella flexneri, and S. Typhimurium
are examples of organisms capable of induc-
ing caspase-1 activation following detection
of the T3SS rod protein [36]. In either case,
flagellin and T3SS rod protein are thought to
gain access to host cell cytosols through ac-
cidental  release  by  the  various  secretion
mechanisms or membrane disrupting activi-
ties required for survival of these organisms
during  infection.  For  instance,  L.  pneu-
mophiladeficient in type IV secretion, S. Ty-
phimurium or P. aeruginosadeficient in type
III secretion, and L. monocytogenesdeficient
in listeriolysin O production all fail to induce
caspase-1  activation  [33,35,37,38].  Thus,
NLRC4 enables host cells to discriminate be-
tween organisms by specifically detecting
activities associated with virulence.
Activation of NLRC4-dependent path-
ways for caspase-1 activation requires sig-
naling  from  an  upstream  NAIP  protein.
Multiple NAIP proteins in mice and the lone
human NAIP protein are able to directly
bind to distinct agonists, resulting in forma-
tion of high molecular weight oligomers
containing NLRC4 [8,9]. These NLRC4-
containing oligomers are competent for cas-
pase-1  recruitment  and  activation  [8,9].
These data indicate that NLRC4 serves as an
adaptor protein for the various NAIP pro-
teins, rather than acting as a direct receptor
for microbial agonists. Instead, it is evident
that NAIPs serve as the primary receptors
and  enable  caspase-1  activation  through
NLRC4 in response to multiple microbial-
derived agonists. NLRC4-dependent cas-
pase-1  activation  mediated  by  bacterial
flagellin has been shown to require NAIP5
in murine macrophages, while signaling in
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ous bacterial species has been shown to re-
quire NAIP2 [8,9]. Interestingly, in contrast
to flagellin- and T3SS rod protein-mediated
activation observed in murine cells, activa-
tion of NLRC4 in human macrophage-like
cells by NAIP occurs in response to T3SS
needle protein [9]. Together, these data indi-
cate that NAIP proteins impart a level of
specificity for the NLRC4 inflammasome.
Future studies should elucidate if other lig-
ands exist for the other NAIP proteins en-
coded in the mouse genome.  
NLRP3
In addition to NLRC4, a major factor in
the caspase-1-mediated response to bacter-
ial-derived molecules is NLRP3. The group
of agonists leading to NLRP3-dependent ac-
tivation of caspase-1 is extensive and con-
tinues  to  grow.  One  class  of  activators
contains a number of bacterial-derived pore-
forming toxins. Examples of pore-forming
toxins that induce NLRP3-dependent cas-
pase-1 activation are streptolysin O (Strep-
tococcus pyogenes) [39], listeriolysin O (L.
monocytogenes) [40], toxin A (Clostridium
difficile) [41], hemolysins (Staphylococcus
aureus) [42], and aerolysin (Aeromonas hy-
drophila) [43]. Activation by pore-forming
toxins is thought to occur as a result of
potassium efflux. It has been demonstrated
that caspase-1 activation induced by pore-
forming toxins can be efficiently blocked by
increasing extracellular potassium concen-
trations [40,42,43]. In addition to pore-form-
ing toxins, other bacterial products appear to
contribute to NLRP3-dependent caspase-1
activation.  S.  Typhimurium  and  Yersinia
spp. induce caspase-1 activation through an
NLRP3-mediated pathway [21,44,45]. The
mechanism for NLRP3 activation by S. Ty-
phimurium is unclear. Activation by Y. pestis
is thought to occur through effector protein
YopJ-mediated inhibition of NF-ʺB signal-
ing, which has been shown previously to
negatively regulate inflammasome activa-
tion [21].  
NLRP3 also has been shown to be im-
portant for sensing of eukaryotic pathogens.
The fungal pathogens Candida albicans and
Aspergillus fumigatus are two examples of
organisms capable of inducing NLRP3-de-
pendent activation of caspase-1 [22,46]. The
mechanism behind activation of NLRP3 in
response to these fungal pathogens is rela-
tively unclear. Studies with C. albicans indi-
cate that uptake of the yeast form of this
pathogen and subsequent differentiation into
the hyphal form is required for efficient acti-
vation of caspase-1 [46]. One hypothesis is
that transition into the hyphal form leads to
phagosomal disruption or reactive oxygen
species production, which in turn stimulates
NLRP3 [46]. In addition to fungal pathogens,
the protozoan genus Plasmodium induces
NLRP3-dependent activation of caspase-1
[15,47,48]. The mode of activation involves a
byproduct of hemoglobin metabolism pro-
duced by the protozoan known as hemozoin.
During the detoxification of heme, which is a
normal part of hemoglobin metabolism by
Plasmodiumparasites, hemozoin is produced
as  an  insoluble  waste  product  [49].  The
mechanism for activation by hemozoin is rel-
atively unclear, although data suggests that
activation may take place indirectly through
the  release  of  uric  acid,  a  well-studied
NLRP3 agonist [48].
Viruses also are sensed by NLRP3-de-
pendent mechanisms. Typically, the sensing
of viruses involves detection of nucleic acid
in the host cell cytosol. It has been demon-
strated that RNA triggers an NLRP3-depen-
dent  inflammasome  [50].  RNA  viruses,
including influenza and sendai virus, are ca-
pable of inducing activation of caspase-1
through NLRP3 [50,51]. Interestingly, in ad-
dition to sensing of viral RNA, NLRP3-de-
pendent activation of caspase-1 occurs in
response to the influenza virus M2 protein,
which acts as a proton-selective ion channel
during viral pathogenesis [52]. It is unclear
how  M2  leads  to  NLRP3  activation,  al-
though the ability of M2 to influence cellu-
lar ionic gradients is likely a factor [52]. 
NLRP1
Anthrax lethal toxin is another example
of a bacterial toxin capable of inducing cas-
pase-1 activation. This toxin is produced by
the bacterium Bacillus anthracis and is ca-
337 Case: Regulating caspase-1 during infectionpable of entering host macrophages through
receptor mediated endocytosis, followed by
translocation of the catalytic subunit of this
protein  complex,  known  as  lethal  factor
(LF), into the host cell cytosol [53]. Once in
the cytosol, LF is sensed by caspase-1 in-
flammasomes in a manner dependent on
NLRP1 (NLRP1b in mice) [54,55]. LF has
been shown previously to possess protease
activity against mitogen-activated protein
kinase kinases (MEKs) [56]. Protease activ-
ity was found to be critical for activation of
caspase-1  by  lethal  factor  in  murine
macrophages [26]. However, MEK cleavage
alone was not sufficient to induce activation,
suggesting that MEK cleavage per se may
not be the signal for caspase-1 activation
through NLRP1b [26]. Furthermore, activa-
tion of caspase-1 by anthrax lethal toxin was
found to require proteasome activity and,
similar to NLRP3, potassium efflux [26,57].
The role of the proteasome during caspase-
1 activation is unclear. One hypothesis is
that NLRP1 is kept in an inactive state by
another  protein  that  becomes  degraded
through  a  proteasome-dependent  mecha-
nism following the sensing of anthrax lethal
toxin.
In addition to anthrax lethal toxin, a
bacterial  cell  wall  component,  muramyl
dipeptide (MDP), has been shown to acti-
vate  caspase-1  through  human  NLRP1
[6,58]. In vitro reconstitution experiments
suggest that MDP may be a direct ligand for
NLRP1, as no other protein components are
required to induce NLRP1 activation in this
setting  [6].  However,  it  remains  unclear
whether a direct interaction between this
bacterial agonist and host sensor protein
takes place in vivo. Furthermore, MDP-me-
diated  activation  of  caspase-1  in  murine
cells  occurs  through  a  NOD2-dependent
mechanism, and it remains unclear whether
a NLRP1 homologue is required for activa-
tion in this system.
AIM2
DNA is also sensed in host cell cytosols
and can induce caspase-1 activation. AIM2
has been shown to directly bind to DNA and
induce inflammasome formation during in-
fection  by  the  intracellular  bacterial
pathogens,  Francisella  tularensis and  L.
monocytogenes [59-65]. In addition to bac-
terial infections, infections by DNA viruses
such as vaccinia virus lead to potent AIM2-
dependent activation of caspase-1 [60]. Sim-
ilar to the NLRPs, activation of caspase-1 by
AIM2 requires the adaptor protein ASC [59-
62].  
NLRP6
In addition to responding to virulent mi-
croorganisms,  caspase-1  inflammasomes
have been shown recently to be critical for
maintaining balance of normal microbiota in
the murine gut. Mice deficient for NLRP6
were found to be colonized more heavily rel-
ative to wild-type mice by several bacterial
species, including members of the bacterial
genus  Prevotella [66].  Consequently,
NLRP6-deficient mice were more suscepti-
ble to dextran sodium sulfate (DSS)-induced
colitis [66]. Resistance to colitis was re-
stored with antibiotic treatment, suggesting
a possible link between increased inflam-
mation and the expansion of Prevotella or
other bacterial species in the gut [66]. Mice
deficient for caspase-1 or the caspase-1-de-
pendent cytokine IL-18 displayed pheno-
types  similar  to  NLRP6-deficient  mice,
suggesting that NLRP6/caspase-1-mediated
production of IL-18 helps to maintain bal-
ance of normal gut microbiota [66]. It is un-
clear whether NLRP6 is directly sensing and
responding to Prevotella or whether the ab-
sence of NLRP6-dependent signaling en-
ables Prevotella persistence and expansion.
These data suggest that inflammasomes may
not only serve as a primary responder to
pathogenic organisms, but also as regulators
of homeostasis among microbial communi-
ties in the host gut.  
reguLAtIon of InfLAMMASoMe
forMAtIon, cytokIne 
proceSSIng And ceLL deAth
Microbe-induced  signaling  through
NLRs or AIM2 ultimately leads to recruit-
ment and activation of caspase-1 via inflam-
masome formation, followed by the action of
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heavily studied activities of caspase-1 in-
clude cleavage of the pro-inflammatory cy-
tokines IL-1ʲ and IL-18 and the induction of
a cell death pathway termed pyroptosis. IL-
1ʲ and IL-18 are synthesized as inactive pre-
cursor proteins (pro-IL-1ʲ and pro-IL-18).
Caspase-1-mediated cleavage of these pro-
teins results in production of the bioactive
form of the cytokines, which are then se-
creted through an unconventional protein se-
cretion  pathway  [1,67].  The  targets  of
caspase-1 that lead to cell death are less clear.
Following caspase-1 activation, pores are
formed in host cell membranes that disrupt
ion fluxes, resulting in osmotic lysis and
death of the cell [68].
In murine macrophages, large inflam-
masome complexes have been observed in
response to agonists of NLRC4, NLRP3,
NLRP1b, and AIM2 [26,34,45,69], suggest-
ing that these structures are a common fea-
ture  of  caspase-1  activation.  These
complexes are organized by the adaptor pro-
tein ASC, which as discussed previously un-
dergoes oligomerization during caspase-1
activation. NLRs and AIM2 may participate
in complex formation by directly associating
with ASC and caspase-1. Recent evidence
using pathogen models have indicated that
caspase-1-mediated cytokine processing and
cell death induction are influenced by the
adaptor ASC. The intracellular pathogens S.
Typhimurium and L. pneumophila induce
NLRC4- and ASC-dependent pathways for
caspase-1 activation in murine macrophages
[25,45]. During infection with these bacte-
ria, complex formation mediated by NLRC4
and ASC is critical for efficient processing
of caspase-1 into its active subunits [69,70].
However, in the absence of ASC-dependent
complex formation, caspase-1-mediated cell
death  via  NLRC4  occurs  normally
[25,38,70,71]. These data suggest that while
NLRs and AIM2 cooperate with ASC in in-
flammasome formation to induce cleavage
of caspase-1, NLRC4 also can function in-
dependently of ASC and direct distinct in-
flammasome formation.
Recent studies have provided evidence
in support of this hypothesis. Reconstitution
studies  using  293T  cells  suggest  that
NLRC4  is  able  to  form  large  molecular
weight complexes with NAIP5 or NAIP2 in
response to flagellin or T3SS rod protein, re-
spectively, and that formation of these com-
plexes are sufficient for induction of cell
death [8]. This complex formation presum-
ably is independent of ASC, as 293T cells
do not express detectable levels of this pro-
tein [72]. This suggests that NLRC4-medi-
ated  pathways  of  caspase-1  activation
involve complex formation distinct from
ASC-dependent  pathways.  Furthermore,
formation of these distinct complexes sig-
nificantly influences downstream caspase-
1-associated activities. Although the ability
of caspase-1 to induce cell death in the ab-
sence of ASC requires the catalytic activity
of the protease, cleavage of caspase-1 is not
required [70]. In fact, a variant of caspase-1
that is unable to undergo proteolytic pro-
cessing is still able to induce pyroptosis. In
contrast, this variant protein is unable to ef-
ficiently  cleave  pro-IL-1ʲ into  its  active
form, even in the presence of ASC [70].
These data suggest that inflammasome for-
mation  through  ASC-dependent  mecha-
nisms leads to caspase-1 autoproteolysis and
that this form of the active protease is criti-
cal for cytokine cleavage. In the absence of
ASC, caspase-1 activation occurs without
autoproteolysis, and this form of the pro-
tease targets a distinct subset of substrates
critical for the induction of pyroptosis [70].
Together, these recent findings indicate that
formation of distinct inflammasomes control
the ability of caspase-1 to target specific
substrates. 
It remains unclear how proteins lacking
a CARD domain, such as NLRP3 and AIM2,
induce cell death through ASC. One possibil-
ity is that the main ASC complex formed in
response to all caspase-1 agonists also pro-
motes cell death. It is possible that within the
ASC  complex,  a  pool  of  caspase-1  is
processed and acts on cytokines to promote
their cleavage and secretion, and an alternate
pool is activated but not processed which then
targets substrates leading to pore formation
and cell death. Alternatively, it cannot be
ruled out that processed and non-processed
339 Case: Regulating caspase-1 during infectioncaspase-1 target the same substrates leading
to cell death and that processed caspase-1
may simply be more efficient at cleavage of
substrates than non-processed caspase-1. In
this scenario, inefficient caspase-1 activity
may have a more drastic consequence on the
levels of cytokines, which are direct targets
of caspase-1. In contrast, it is possible that
caspase-1-mediated cell death may involve a
signal  amplification  cascade  that  requires
very little caspase-1 activity in order to initi-
ate the pathway. Future studies examining the
substrates of processed and non-processed
caspase-1 will provide more insight into the
ability of caspase-1 to differentially regulate
cytokine processing and cell death.
concLuSIonS
Studies  examining  macrophage  re-
sponses to microbial pathogens and their as-
sociated molecules have yielded significant
mechanistic insight into caspase-1 activa-
tion and regulation. A diverse class of cy-
tosolic sensor proteins comprised of the
NLRs and AIM2 enables host cells to detect
a range of microbial products that gain ac-
cess to host cell cytosols. Sensing of micro-
bial  products  by  NLRs  and  AIM2  may
occur through direct binding of an agonist
to a sensor protein, production of interme-
diate signals that bind to a sensor protein,
or detection of an overall change in the cel-
lular environment. Ultimately, different sig-
nals  are  able  to  converge  on  caspase-1
through the adaptor ASC, which organizes
specialized platforms leading to caspase-1
processing  and  cytokine  cleavage.  Inde-
pendent of ASC-mediated complex forma-
tion, caspase-1 can be directly recruited and
activated  by  NLRC4  and  possibly  other
sensors without processing, leading to in-
duction of cell death. Studies thus far have
uncovered mechanisms for regulating cas-
pase-1 specificity with respect to cytokine
secretion and induction of cell death. Future
work in this area will likely identify roles
for previously uncharacterized NLRs and
further elucidate mechanistic details behind
NLR activation and regulation of caspase-1-
mediated activities.    
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